Drug overdose deaths among teenagers surged during the pandemic driven by illicit fentanyl

Drug overdose deaths among teenagers surged during the pandemic driven by illicit fentanyl


Drug overdose deaths among adolescents surged during the Covid-19 pandemic, driven overwhelmingly by illicit fentanyl, according to a report from the Centers for Disease Control and Prevention.

Monthly drug overdose deaths nearly tripled among adolescents ages 10 to 19 during the first two years of the pandemic. Deaths rose from 31 in July 2019 to a peak of 87 in May 2021 and then fell to 51 in December 2021.

“Although deaths appear to have begun declining in late 2021, they are still alarmingly higher than in 2019,” the authors wrote in the CDC’s Morbidity and Mortality Weekly Report, which published Thursday.

More than 2,200 adolescents overdosed during the 2½ year period, 96% of whom were teenagers ages 15 to 19. Fentanyl was involved in 84% of the deaths while opioids of any type were involved in 91%.

Fentanyl deaths among adolescents nearly quadrupled from 21 in July 2019 to a peak of 78 in May 2021 and then declined to 44 in December 2021.

About 70% of the victims were boys and 30% were girls. Some 60% of those who died were white, 21% were Hispanic and 13% were Black.

Fentanyl is a synthetic opioid that’s up to 100 times more potent than morphine, according to the National Institute on Drug Abuse. It’s used as a prescription drug in the U.S. to treat people suffering from severe pain after surgery. But illegally manufactured fentanyl, often consumed as a pill, has become an increasingly common cause of overdose deaths.

There was evidence that 25% of adolescent overdose deaths may have involved counterfeit pills that often resemble OxyContin or Xanax but frequently include fentanyl as well. This is likely an underestimate because pills present at the scenes weren’t always tested, according to the study.

“Whether adolescents intended to take legitimate pharmaceutical medications or were aware pills were counterfeit is unclear,” the authors wrote.

About 41% of those who overdosed had a previous history mental health issues. Some 24% had mental health treatment before, 19% were diagnosed with depression, and 15% had a prior history of suicidal or self-harm behavior.

The authors of the CDC study said its crucial to educate teenagers on the dangers of fentanyl and to expand access to naloxone, a drug that can reverse an overdose. Teens should also be educated about the potential presence of illicit fentanyl in pills that may resemble prescription drugs.

If you are having suicidal thoughts or are in distress, contact the Suicide & Crisis Lifeline at 988 for support and assistance from a trained counselor.



Source

Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Health

Trump’s pharmaceutical tariffs could affect some drugmakers more than others

Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]

Read More
Merck plans  billion cost cuts by end of 2027, narrows full-year outlook
Health

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches […]

Read More
UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers
Health

UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers

UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023. Patrick T. Fallon | Afp | Getty Images UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s insurance unit continues to grapple with higher medical costs. The company anticipates it will […]

Read More